The role of the soluble fms-like tyrosin kinase-1 / the placental growth factor ratio in the diagnostics of preeclampsia in physiological pregnancy and pregnancy after IVF
- 作者: Ivanets T.Y.1, Kan N.E.1, Tyutyunnik V.L.1, Bezzubenko Y.V.1, Ibragimov R.R.1
-
隶属关系:
- Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- 期: 编号 3 (2018)
- 页面: 37-42
- 栏目: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248158
- DOI: https://doi.org/10.18565/aig.2018.3.37-42
- ID: 248158
如何引用文章
详细
全文:
![受限制的访问](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
作者简介
Tatiana Ivanets
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: t_ivanets@oparina4.ru
the head of the clinical laboratory
Natalia Kan
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: kan-med@mail.ru
PhD, MD, the head of the obstetric department
Victor Tyutyunnik
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: tioutiounnik@mail.ru
PhD, MD, the head of the obstetric physiological department
Yulia Bezzubenko
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: j_bezzubenko@mail.ru
doctor for clinical laboratory diagnostics of the clinical laboratory
Ruslan Ibragimov
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: r_ibragimov@oparina4.ru
specialist in automated systems of protection
参考
- Серов В.Н., Кан Н.Е., Тютюнник В.Л. Прогностическое значение отношения растворимой fms-подобной тирозинкиназы-1 к плацентарному фактору роста у беременных с преэклампсией. Акушерство и гинекология. 2016; 6: 5-10. http://dx.doi.org/10.18565/aig.2016.6.5-10
- Ходжаева З.С., Коган Е.А., Клименченко Н.И., Акатьева А.С., Сафонова А.Д., Холин А.М., Вавина О.В., Сухих Г.Т. Клинико-патогенетические особенности ранней и поздней преэклампсии. Акушерство и гинекология. 2015; 1: 12-7.
- Lamarca B. Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia. Minerva Ginecol. 2012; 64(4): 309-20.
- Reddy A., Suri S., Sargent I.L., Redman C.W., Muttukrishna S. Maternal circulating levels of activin A., inhibin A., sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia. PLoS One. 2009; 4(2): e4453.
- Moore Simas T.A., Crawford S.L., Solitro M.J., Frost S.C., Meyer B.A., Maynard S.E. Angiogenic factors for the prediction of preeclampsia in high-risk women. Am. J. Obstet. Gynecol. 2007; 197(3): 244. e1-8.
- Foidart Y.M., Schaaps Y.P., Chantraine F., Munaut C., Lorquet S. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia - a step forward but not the definitive answer. J. Reprod. Immunol. 2009; 82(2): 106-11.
- Kvehaugen A.S., Deckend R., Ramstad H.B., Troisi R., Fugelseth D., Staff A.C. Endothelial function and circulating biomarkers are disturbed in women and children after preeclampsia. Hypertension. 2011; 58(1): 63-9.
- Иванец Т.Ю., Алексеева М.Л., Кан Н.Е., Тютюнник В.Л., Амирасланов Э.Ю., Насонова Д.М., Фанченко Н.Д. Диагностическая значимость определения плацентарного фактора роста и растворимой fms-подобной тирозинкиназы-1 в качестве маркеров преэклампсии. Проблемы репродукции. 2015; 21(4): 129-33.
- Staff A.C. Circulating predictive biomarkers in preeclampsia. Pregnancy Hypertens. 2011; 1(1): 28-42.
- Vatten L.J., Eskild A., Nilsen T.I., Jeansson S., Jenum P.A., Staff A.C. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia. Am. J. Obstet. Gynecol. 2007; 196(3): 239-46.
- Wang A., Rana S., Karumanchi S.A. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda). 2009; 24: 147-58.
- Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F. et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 2004; 350(7): 672-83.
- Wikström A.K., Larsson A., Eriksson U.J., Nash P., Nordén-Lindeberg S., Olovsson M. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstet. Gynecol. 2007; 109(6): 1368-74.
- Verfahren S., Herraiz I., Lapaire O., Schlembach D., Moertl M., Zeisler H. et al. The sFlt-1/PlGF radio in different types of hypertensive pregnancy disorders and its prognostic potential in peeclamptic patients. Am. J. Obstet. Gynecol. 2012; 206(1): 58: e1-8.
- Jelliffe-Pawlowski L.L., Shaw G.M., Currier R.J., Stevenson D.K., Baer R.J., O’Brodovich H.M., Gould J.B. Association of early preterm birth with abnormal levels of rutinely collected ferst- and second-thrimester biomarkers. Am. J. Obstet. Gynecol. 2013; 208(6): 492. e1-11.
- Husse S., Gottschlich A., Schrey S., Stepan H., Hoffmann J. Predictive value of the sFlt1/PlGF ratio for the diagnosis of preeclampsia in high-risk patients. Z. Geburtshilfe Neonatol. 2014; 218(1): 34-41.
补充文件
![](/img/style/loading.gif)